Latest News in the pharma Industry
Research & Development
Nintedanib Receives Positive CHMP Opinion in European Union for the Treatment of Idiopathic Pulmonary Fibrosis
25 Nov 2014
Read more
Amgen Terminates All Amgen-Sponsored Clinical Studies of Rilotumumab in Advanced Gastric Cancer
24 Nov 2014
Read more
Novartis Cosentyx Receives Positive CHMP Opinion for First-Line Treatment of Moderate-to-Severe Psoriasis Patients?
21 Nov 2014
Read more
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis
20 Nov 2014
Read more